12Oct

Welcome back to #WeAreGreenKey, where we shine a spotlight on our powerhouse agency team.  

We met up with Krista Zielinski, Principal at Green Key leading the Pharmaceutical Orlando team. Krista started her staffing career more than a decade ago, transitioning to recruiting in 2010.

What led you to pursue a career in Pharma recruiting and what do you find most rewarding about your work?

I started my recruiting career in 2007 working in a support role on the sales side of staffing. I moved over to the recruiting side in 2010 with Green Key and this is where I’ve been ever since. I love being able to help others through their career journey.  Being able to see them progress through their career, sharing advice, and building long-term relationships is what I find the most rewarding.

What are current trends and challenges in pharmaceutical recruitment that clients should be aware of?

During the pandemic, almost all our positions moved to fully remote, and many employees adjusted their lives, homes and physical locations around that new model. The current challenge in today’s environment is that companies are moving back to a hybrid/on-site model, but employees are resistant or unable to fulfill that request, and many will only consider a fully remote arrangement.

How important is industry-specific knowledge when collaborating with clients and determining their needs?

Understanding the industry and staying up to date on our clients is extremely important. Our clients depend on us to respond quickly when they have new positions to fill or are facing downsizing situations. Staying abreast of news both positive and negative helps us prepare to support them during these times. 

How do you stay updated on changes and developments within the pharmaceutical industry to better serve your clients and candidates?

There are a lot of resources available to stay updated on changes and developments within the industry. I personally subscribe to various industry newsletters and articles that highlight significant topics but also offer insight into other intriguing parts of our industry.

Do you have any new professional goals, either for yourself or your team?

Yes! A professional goal we have as a team (and personally) is to focus on strengthening our relationships with our clients and candidates with the aim of setting ourselves apart from other agencies. Our goal is to fortify the bonds we’ve created to ensure we are offering the best support possible to our current and future clients and candidates. 

Apr 16, 2024

Biotech vs. Techbio: A Nexus of Biology and Tech

In the dynamic world of scientific innovation, two terms have emerged as guiding lights: Biotech and Techbio. These terms encapsulate distinct yet complementary approaches to leveraging technology for advancements in the realm of biology. Let’s delve into the nuances of each and explore their shared mission at the intersection of science and technology.

Biotech vs Techbio

According to Bioindustry.org, “Biotech, short for biotechnology, is a broad field that encompasses living organisms or parts of living organisms to make products, improve plants or animals, or develop new processes for various industries.” While Techbio is, “…‘tech bio’ is the exciting new field focused on leveraging data and technology to improve, enhance, and accelerate life science processes,” as stated by Forbes.

Medium.com goes further to explain techbio stating, “TechBio is the direct application of engineering to biology. While the portion of biology that we understand is still severely limited in scope, applying an engineering mindset to solving biological problems means we can still work with limited information. We see TechBio as being concerned with four main components:

  • Reading bio — understanding genetic information (DNA, RNA, proteins, etc.) ex: next-gen sequencing
  • Writing bio — synthesizing DNA, RNA, and protein constructs. ex: creating custom DNA oligonucleotides
  • Programming bio — manipulating genetic information or small molecules for therapeutic purposes. ex: designing complex antibody drugs to treat metastatic cancer
  • Delivering bio — routing biological information to the correct tissues and cells. ex: delivering RNA drugs to organ of interest

Simply put, techbio focuses on leveraging computational tools and techniques to analyze, model, and understand biological data. With the exponential growth of data generated by genomics, proteomics, and other ‘omics disciplines, techbio plays a crucial role in decoding the complexities of living systems. Through algorithms, machine learning, and data visualization, techbio enables researchers to unravel biological mysteries, predict disease outcomes, and design novel therapeutics with unprecedented precision.

Bridging the Gap

While biotech and techbio represent distinct approaches, the boundaries between the two are increasingly blurred as interdisciplinary collaborations flourish. These collaborations are evidence and projects ranging from personalized medicine initiatives to the development of sustainable biomanufacturing processes. These collaborations leverage the strengths of both the disciplines, resulting in transformative advancements in real-world impact.

Whether it’s engineering microbes for biofuel production or using machine learning to predict protein structures, the convergence of biotech and tech bio holds immense promise for addressing pressing global challenges.

The convergence of biotech and tech bio marks an exciting era of discovery and innovation at the Nexus of biology and technology. Their collaborative synergy holds immense promise for addressing the complex challenges facing humanity from advancing healthcare to enhancing food security and environmental sustainability.